Head of Clinical Operations

As the new Head of Clinical Operations, you will be spearheading the Clinical Operations Department and setting the direction for a growing portfolio of clinical trials Phase 2-4 as well as pharmacology trails.

Ensure the advancement of Pharmacosmos clinical trial portfolio
As the Head of Clinical Operations for Pharmacosmos, you will report to the Head of Clinical Development and provide strategic and operational guidance for the Clinical Operations Department including 7 skilled internal and external clinical operations professionals. In this role, you will be defining its direction, developing structures, and driving continuous development and improvement of clinical processes in accordance with GCP. This also includes strategic planning, communication, coordination, delegation, and stepping into direct action as necessary to make sure goals are achieved on time and budget. Furthermore, you are responsible for efficient vendor management strategies, ensuring selection, management, delivery and budget follow ups and oversight of Clinical Research Organizations (CROs), vendors, and other third parties. Further, you are going to lead the development of operational strategies for identifying, recruiting, and retaining trial sites and subjects, including being in forefront of current best practices and tools for site selection and patient recruitment. The role also encompasses risk assessment and mitigation plans for clinical trials, ensuring timely identification and resolution of issues. Leading the budgeting processes for clinical programs, you will align financial resources with project timelines and requirements. Finally, you will promote a culture of continuous improvement within the Clinical Operation Department, enhancing clinical trial capabilities, effectiveness, and value delivery.

Experienced Clinical Operations profile
We expect you to hold a relevant degree within the field of life science, combined with extensive experience from the pharmaceutical industry, specifically focused on clinical operations management. You possess proven leadership/management capabilities, coupled with solid experience in managing phase 2 and 3 clinical trials. Further, you have an excellent understanding of as well as demonstrated application of Good Clinical Practices (GCP), ICH and other relevant guidelines. Moreover, you have previous experience managing CROs. Finally, your expertise includes the ability to lead and manage a wide variety of internal and external stakeholders, and you excel in meeting timelines and reaching corporate goals.

Personally, you are structured, proactive, responsible, and ambitious with an empathic and respectful mindset. You are a strong, adaptable leader, who knows how to set the direction for your team and how to influence, motivate, and bring people together and encourage growth. Demonstrating excellent planning, coordination, and prioritization skills, you can work independently as well as in a collaborative environment. Your robust ethical foundation fosters a profound dedication to integrity and an unwavering commitment to quality in all of your work, empowering you to effectively navigate through ambiguity and change. Finally, you have excellent proficiency in English both written and spoken.

Play a crucial role in an exciting international growth journey
This is your chance to embark upon a personal and organizational journey in a dynamic company where your know-how is greatly needed for the future development of Pharmacosmos. The recruitment process is carried out by Venaris Executive Search. For more information regarding the position, please reach out to Sr. Executive Search Consultant, Lars Nordlund on +45 3123 3018. All requests will be handled confidentially. If this position is for you, do not hesitate to apply by uploading your CV - it is not necessary to include a cover letter.

Pharmacosmos
Founded in 1965, Pharmacosmos is a global healthcare pioneer in carbohydrate chemistry and a leader in the development of innovative treatments for blood diseases, including iron deficiency anemia and cryopreservation technology. On September 18th, 2024, Pharmacosmos announced the successful completion of their acquisition of G1 Therapeutics, a commercial-stage oncology company. The acquisition aligns perfectly with Pharmacosmos' strategy by leveraging their extensive expertise in blood diseases, positioning the company for its next phase of growth and strengthening its global commercial portfolio. Headquartered in Holbæk, Denmark, Pharmacosmos employs 650 dedicated employees, with products marketed in over 40 countries worldwide. Please also visit www.pharmacosmos.com